MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Association of vitamin D deficiency in Parkinson disease

A. MUJTABA, N. ALSOMALI, A. ALSHAMRANI, S. MARAR, T. Alayan, J. BAJWA (RIYADH, Saudi Arabia)

Meeting: 2017 International Congress

Abstract Number: 1186

Keywords: Parkinsonism

Session Information

Date: Thursday, June 8, 2017

Session Title: Clinical Trials and Therapy in Movement Disorders

Session Time: 1:15pm-2:45pm

Location: Exhibit Hall C

Objective: To identify the association between vitamin D deficiency and  PD in an Arab cohort.

 

Background: A growing body of evidence suggests that vitamin D deficiency may affect the incidence and progression of Parkinson’s disease, but data from ethnic  populations are lacking.

Methods: Methods and Results

We studied  157  subjects (84 PD subjects and 63 controls) with mean age of 61.5 years. Vitamin D status was assessed by measuring 25-dihydroxyvitamin D (25-OH D) levels. Overall, 35.7% of PD subjects had lower-than-normal blood levels of vitamin D (<30 ng/mL), and 7.1% had vitamin D deficiency  (<15 ng/mL), while, 15.8% of controls had low vitamin D (<30 ng/mL) which was statistically significant (p =0,0034). Mean vitamin D level in PD subjects was 46.2 ng/mL, and in controls 59.9 ng/mL (OR 3.10 ; 95% confidence interval 1.3817 to 6.9554, (P =0.0061).  PD patients with early onset PD (age less than 55) were 31 and 41.9 % of them had vitamin D deficiency. However, no significant associations were found between vitamin D deficiency and early onset PD (p =0.25).

Results: We studied  157  subjects (84 PD subjects and 63 controls) with mean age of 61.5 years. Vitamin D status was assessed by measuring 25-dihydroxyvitamin D (25-OH D) levels. Overall, 35.7% of PD subjects had lower-than-normal blood levels of vitamin D (<30 ng/mL), and 7.1% had vitamin D deficiency  (<15 ng/mL), while, 15.8% of controls had low vitamin D (<30 ng/mL) which was statistically significant (p =0,0034). Mean vitamin D level in PD subjects was 46.2 ng/mL, and in controls 59.9 ng/mL (OR 3.10 ; 95% confidence interval 1.3817 to 6.9554, (P =0.0061).  PD patients with early onset PD (age less than 55) were 31 and 41.9 % of them had vitamin D deficiency. However, no significant associations were found between vitamin D deficiency and early onset PD (p =0.25). 

Conclusions: The results suggest  association of vitamin D deficiency [serum 25(OH)D <30 ng/mL] and PD.  Further clinical studies in a larger cohort are required to determine association of Vit. D in PD.  

To cite this abstract in AMA style:

A. MUJTABA, N. ALSOMALI, A. ALSHAMRANI, S. MARAR, T. Alayan, J. BAJWA. Association of vitamin D deficiency in Parkinson disease [abstract]. Mov Disord. 2017; 32 (suppl 2). https://www.mdsabstracts.org/abstract/association-of-vitamin-d-deficiency-in-parkinson-disease/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/association-of-vitamin-d-deficiency-in-parkinson-disease/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley